M
Malorie Chabot-Blanchet
Researcher at Montreal Heart Institute
Publications - 15
Citations - 552
Malorie Chabot-Blanchet is an academic researcher from Montreal Heart Institute. The author has contributed to research in topics: Placebo & Medicine. The author has an hindex of 7, co-authored 14 publications receiving 320 citations. Previous affiliations of Malorie Chabot-Blanchet include Université de Montréal.
Papers
More filters
Journal ArticleDOI
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
Jean-Claude Tardif,Nadia Bouabdallaoui,Philippe L. L’Allier,Daniel Gaudet,Binita Shah,Michael H. Pillinger,Jose Lopez-Sendon,Protasio da Luz,Lucie Verret,Sylvia Audet,Jocelyn Dupuis,André Y. Denault,Martin Pelletier,Philippe A. Tessier,Sarah Samson,Denis Fortin,J.C. Tardif,David Busseuil,Elisabeth Goulet,Chantal Lacoste,Anick Dubois,Avni Y. Joshi,David D. Waters,Priscilla Y. Hsue,Norman E. Lepor,Frédéric Lesage,Nicolas Sainturet,Eve Roy-Clavel,Zohar Bassevitch,Andreas Orfanos,Gabriela Stamatescu,Jean Grégoire,Lambert Busque,Christian Lavallée,Pierre-Olivier Hétu,Jean-Sébastien Paquette,Spyridon Deftereos,Sylvie Levesque,Mariève Cossette,Anna Nozza,Malorie Chabot-Blanchet,Marie-Pierre Dubé,Marie-Claude Guertin,Guy Boivin +43 more
TL;DR: The COLCORONA trial as mentioned in this paper investigated the effect of colchicine on the composite of COVID-19-related death or hospital admission and found that colchics led to a lower rate of the composite adverse events than placebo.
Journal ArticleDOI
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access: The Campeau Radial Paradox
Lorenzo Azzalini,Kunle Tosin,Malorie Chabot-Blanchet,Robert Avram,Hung Q. Ly,Benoit Gaudet,Richard L. Gallo,Serge Doucet,Jean-François Tanguay,Reda Ibrahim,Jean Grégoire,Jacques Crépeau,Raoul Bonan,Pierre de Guise,Mohamed Nosair,Jean-François Dorval,Gilbert Gosselin,Philippe L. L’Allier,Marie-Claude Guertin,Anita W. Asgar,E. Marc Jolicœur +20 more
TL;DR: In a contemporary population where both RA and FA were used, the safety benefit associated with RA is offset by a paradoxical increase in VASCs among FA patients, consistent for both diagnostic and therapeutic catheterizations separately.
Journal ArticleDOI
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study.
Robert Bissonnette,François Harel,James G. Krueger,Marie-Claude Guertin,Malorie Chabot-Blanchet,Juana Gonzalez,Catherine Maari,Isabelle Delorme,Charles Lynde,Jean-Claude Tardif +9 more
TL;DR: This study showed no difference over 16 weeks in vascular inflammation in patients treated with a tumor necrosis factor-α antagonist or placebo and a modest increase in vascularinflammation in carotids after 52 weeks of treatment with adalimumab.
Journal ArticleDOI
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
Rebecca Taub,Edward Chiang,Malorie Chabot-Blanchet,Kelly Martha,Richard A. Reeves,Marie-Claude Guertin,Jean-Claude Tardif +6 more
TL;DR: In a two-week study in healthy volunteers with mild LDL cholesterol elevation, MGL-3196 appeared safe, was well-tolerated and showed a beneficial effect on lipid parameters, which was observed at a dose of 80 mg daily.
Posted ContentDOI
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
Jean-Claude Tardif,Nadia Bouabdallaoui,Philippe L. L’Allier,Daniel Gaudet,Binita Shah,Michael H. Pillinger,Jose Lopez-Sendon,Protasio da Luz,Lucie Verret,Sylvia Audet,Jocelyn Dupuis,André Y. Denault,Martin Pelletier,Philippe A. Tessier,Sarah Samson,Denis Fortin,J.C. Tardif,David Busseuil,Elisabeth Goulet,Chantal Lacoste,Anick Dubois,Avni Y. Joshi,David D. Waters,Priscilla Y. Hsue,Norman E. Lepor,Frédéric Lesage,Nicolas Sainturet,Eve Roy-Clavel,Zohar Bassevitch,Andreas Orfanos,Jean Grégoire,Lambert Busque,Christian Lavallée,Pierre-Olivier Hétu,Jean-Sébastien Paquette,Sylvie Levesque,Mariève Cossette,Anna Nozza,Malorie Chabot-Blanchet,Marie-Pierre Dubé,Marie-Claude Guertin,Guy Boivin +41 more
TL;DR: A randomized, double-blind trial involving non-hospitalized patients with COVID-19 diagnosed by polymerase chain reaction (PCR) testing or clinical criteria was performed in this article.